246 related articles for article (PubMed ID: 25936721)
21. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients.
Gómez-Zorrilla S; Camoez M; Tubau F; Periche E; Cañizares R; Dominguez MA; Ariza J; Peña C
Antimicrob Agents Chemother; 2014 Oct; 58(10):5863-70. PubMed ID: 25049255
[TBL] [Abstract][Full Text] [Related]
22. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
24. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM
J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042
[TBL] [Abstract][Full Text] [Related]
25. Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients.
Balandin B; Ballesteros D; Ruiz de Luna R; López-Vergara L; Pintado V; Sancho-González M; Soriano-Cuesta C; Pérez-Pedrero MJ; Asensio-Martín MJ; Fernández-Simón I; Rodríguez-Serrano D; Silva A; Chicot M; Iranzo R; Martínez-Sagasti F; Royuela A
Int J Antimicrob Agents; 2021 Mar; 57(3):106270. PubMed ID: 33347991
[TBL] [Abstract][Full Text] [Related]
26. Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen.
Hedrick TL; Schulman AS; McElearney ST; Smith RL; Swenson BR; Evans HL; Truwit JD; Scheld WM; Sawyer RG
Surg Infect (Larchmt); 2008 Apr; 9(2):139-52. PubMed ID: 18426346
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
Joo EJ; Kang CI; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Lee NY; Song JH
Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966
[TBL] [Abstract][Full Text] [Related]
28. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
30. In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.
Solé M; Fàbrega A; Cobos-Trigueros N; Zamorano L; Ferrer-Navarro M; Ballesté-Delpierre C; Reustle A; Castro P; Nicolás JM; Oliver A; Martínez JA; Vila J
J Antimicrob Chemother; 2015 Nov; 70(11):3004-13. PubMed ID: 26260130
[TBL] [Abstract][Full Text] [Related]
31. Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes.
Harris AD; Jackson SS; Robinson G; Pineles L; Leekha S; Thom KA; Wang Y; Doll M; Pettigrew MM; Johnson JK
Infect Control Hosp Epidemiol; 2016 May; 37(5):544-8. PubMed ID: 26832307
[TBL] [Abstract][Full Text] [Related]
32. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.
Buhl M; Peter S; Willmann M
Expert Rev Anti Infect Ther; 2015; 13(9):1159-70. PubMed ID: 26153817
[TBL] [Abstract][Full Text] [Related]
35. Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department.
Angrill N; Gallego M; Font J; Vallés J; Morón A; Monsó E; Rello J
BMC Pulm Med; 2020 Apr; 20(1):83. PubMed ID: 32245452
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
[TBL] [Abstract][Full Text] [Related]
37. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.
Hsu DI; Okamoto MP; Murthy R; Wong-Beringer A
J Antimicrob Chemother; 2005 Apr; 55(4):535-41. PubMed ID: 15728150
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa.
Eagye KJ; Kuti JL; Nicolau DP
Infect Control Hosp Epidemiol; 2009 Aug; 30(8):746-52. PubMed ID: 19583513
[TBL] [Abstract][Full Text] [Related]
39. Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance.
Cohen MJ; Block CS; Moses AE; Nir-Paz R
Clin Microbiol Infect; 2014 Mar; 20(3):O188-96. PubMed ID: 24102767
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation.
Tebano G; Geneve C; Tanaka S; Grall N; Atchade E; Augustin P; Thabut G; Castier Y; Montravers P; Desmard M
Transpl Infect Dis; 2016 Feb; 18(1):22-30. PubMed ID: 26455730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
